Interchangeability Issues with Glaucoma Medicines Using Latanoprost as an Example


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

The possible interchangeability of eye drops was analyzed using glaucoma medicines containing latanoprost as examples. It was shown that the reference and generic drugs could be identical with respect to composition of active ingredients when manufactured from the same pharmaceutical substance but could differ in the excipient composition, in particular, have a different buffer and osmolality that could produce differences in their clinical effects. An analysis of the literature showed that the therapeutic efficacy and safety could vary for pharmaceutically equivalent drugs. The lack of therapeutic equivalence on the background of pharmaceutical equivalence could be caused by the use of different packaging and different dosing systems. Therefore, results from clinical trials must be compared to confirm the interchangeability of eye drops.

作者简介

N. Bunyatyan

Institute of Professional Education, I. M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia; Scientific Center for Expert Evaluation of Medicinal Products, Ministry of Health of the Russian Federation

Email: chem@folium.ru
俄罗斯联邦, 8/2 Trubetskaya St., Moscow, 119991; 8/2 Petrovskii Blvd., Moscow, 127051

O. Filippova

Institute of Professional Education, I. M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia

Email: chem@folium.ru
俄罗斯联邦, 8/2 Trubetskaya St., Moscow, 119991

B. Romanov

Institute of Professional Education, I. M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia

Email: chem@folium.ru
俄罗斯联邦, 8/2 Trubetskaya St., Moscow, 119991

A. Prokof’ev

Scientific Center for Expert Evaluation of Medicinal Products, Ministry of Health of the Russian Federation

Email: chem@folium.ru
俄罗斯联邦, 8/2 Petrovskii Blvd., Moscow, 127051


版权所有 © Springer Science+Business Media, LLC, part of Springer Nature, 2018
##common.cookie##